Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$263.97 - $344.64 $501,543 - $654,816
1,900 New
1,900 $635,000
Q1 2022

May 17, 2022

BUY
$524.57 - $735.42 $2.47 Million - $3.46 Million
4,700 Added 940.0%
5,200 $2.93 Million
Q4 2021

Feb 15, 2022

SELL
$708.84 - $794.68 $283,536 - $317,872
-400 Reduced 44.44%
500 $378,000
Q3 2021

Nov 16, 2021

BUY
$657.71 - $825.77 $131,542 - $165,154
200 Added 28.57%
900 $671,000
Q2 2021

Aug 16, 2021

SELL
$576.64 - $649.04 $1.5 Million - $1.69 Million
-2,600 Reduced 78.79%
700 $451,000
Q1 2021

May 18, 2021

BUY
$547.01 - $662.35 $1.26 Million - $1.52 Million
2,300 Added 230.0%
3,300 $1.89 Million
Q4 2020

Feb 17, 2021

BUY
$510.68 - $643.45 $510,680 - $643,450
1,000 New
1,000 $583,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.19B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.